APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pet Drug and Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pet Drug and Vaccine Market Outlook and Growth Opportunities 2026

Report ID 17402420042 January 2026197 pages

Choose your research edition.

Industry ResearchPet Drug and Vaccine Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Pet Drug and Vaccine Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Pet Drug and Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pet Drug and Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Pet Drug and Vaccine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Pet Drug and Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pet Drug and Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pet Drug and Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pet Drug and Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pet Drug and Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pet Drug and Vaccine market include Boehringer Ingelheim, Ceva, Dechra Veterinary Products, Elanco Animal Health, Meiji, Merck Animal Health, Ouro Fino Saude, Parnell and Vetoquinol, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pet Drug and Vaccine market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pet Drug and Vaccine and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pet Drug and Vaccine revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pet Drug and Vaccine market.

Pet Drug and Vaccine Segment by Company

Boehringer Ingelheim

Ceva

Dechra Veterinary Products

Elanco Animal Health

Meiji

Merck Animal Health

Ouro Fino Saude

Parnell

Vetoquinol

Virbac

Zoetis

Pet Drug and Vaccine Segment by Type

Drugs

Vaccine

Pet Drug and Vaccine Segment by Application

Dogs

Cats

Other

Pet Drug and Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Pet Drug and Vaccine status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pet Drug and Vaccine key companies, revenue, market share, and recent developments.

3. To split the Pet Drug and Vaccine breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pet Drug and Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pet Drug and Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze Pet Drug and Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Drug and Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Drug and Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Drug and Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pet Drug and Vaccine industry.

Chapter 3: Detailed analysis of Pet Drug and Vaccine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pet Drug and Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pet Drug and Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pet Drug and Vaccine Industry Trends Table 2. Pet Drug and Vaccine Industry Drivers Table 3. Pet Drug and Vaccine Industry Opportunities and Challenges Table 4. Pet Drug and Vaccine Industry Restraints Table 5. Global Pet Drug and Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pet Drug and Vaccine Revenue Share by Company (2021-2026) Table 7. Global Pet Drug and Vaccine Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pet Drug and Vaccine Key Company Manufacturing Base & Headquarters Table 9. Global Pet Drug and Vaccine Company, Product Type & Application Table 10. Global Pet Drug and Vaccine Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pet Drug and Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Drugs Table 15. Significant Companies of Vaccine Table 16. Global Pet Drug and Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Pet Drug and Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Pet Drug and Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Pet Drug and Vaccine Sales Value Share by Type (2021-2026) Table 20. Global Pet Drug and Vaccine Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Dogs Table 22. Significant Companies of Cats Table 23. Significant Companies of Other Table 24. Global Pet Drug and Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Pet Drug and Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Pet Drug and Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Pet Drug and Vaccine Sales Value Share by Application (2021-2026) Table 28. Global Pet Drug and Vaccine Sales Value Share by Application (2027-2032) Table 29. Global Pet Drug and Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Pet Drug and Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Pet Drug and Vaccine Sales Value Share by Region (2021-2026) Table 32. Global Pet Drug and Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Pet Drug and Vaccine Sales Value Share by Region (2027-2032) Table 34. Global Pet Drug and Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Pet Drug and Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Pet Drug and Vaccine Sales Value Market Share by Country (2021-2026) Table 37. Global Pet Drug and Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Pet Drug and Vaccine Sales Value Market Share by Country (2027-2032) Table 39. Boehringer Ingelheim Company Information Table 40. Boehringer Ingelheim Business Overview Table 41. Boehringer Ingelheim Pet Drug and Vaccine Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Boehringer Ingelheim Pet Drug and Vaccine Product Portfolio Table 43. Boehringer Ingelheim Recent Development Table 44. Ceva Company Information Table 45. Ceva Business Overview Table 46. Ceva Pet Drug and Vaccine Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Ceva Pet Drug and Vaccine Product Portfolio Table 48. Ceva Recent Development Table 49. Dechra Veterinary Products Company Information Table 50. Dechra Veterinary Products Business Overview Table 51. Dechra Veterinary Products Pet Drug and Vaccine Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Dechra Veterinary Products Pet Drug and Vaccine Product Portfolio Table 53. Dechra Veterinary Products Recent Development Table 54. Elanco Animal Health Company Information Table 55. Elanco Animal Health Business Overview Table 56. Elanco Animal Health Pet Drug and Vaccine Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Elanco Animal Health Pet Drug and Vaccine Product Portfolio Table 58. Elanco Animal Health Recent Development Table 59. Meiji Company Information Table 60. Meiji Business Overview Table 61. Meiji Pet Drug and Vaccine Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Meiji Pet Drug and Vaccine Product Portfolio Table 63. Meiji Recent Development Table 64. Merck Animal Health Company Information Table 65. Merck Animal Health Business Overview Table 66. Merck Animal Health Pet Drug and Vaccine Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Merck Animal Health Pet Drug and Vaccine Product Portfolio Table 68. Merck Animal Health Recent Development Table 69. Ouro Fino Saude Company Information Table 70. Ouro Fino Saude Business Overview Table 71. Ouro Fino Saude Pet Drug and Vaccine Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Ouro Fino Saude Pet Drug and Vaccine Product Portfolio Table 73. Ouro Fino Saude Recent Development Table 74. Parnell Company Information Table 75. Parnell Business Overview Table 76. Parnell Pet Drug and Vaccine Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Parnell Pet Drug and Vaccine Product Portfolio Table 78. Parnell Recent Development Table 79. Vetoquinol Company Information Table 80. Vetoquinol Business Overview Table 81. Vetoquinol Pet Drug and Vaccine Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Vetoquinol Pet Drug and Vaccine Product Portfolio Table 83. Vetoquinol Recent Development Table 84. Virbac Company Information Table 85. Virbac Business Overview Table 86. Virbac Pet Drug and Vaccine Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Virbac Pet Drug and Vaccine Product Portfolio Table 88. Virbac Recent Development Table 89. Zoetis Company Information Table 90. Zoetis Business Overview Table 91. Zoetis Pet Drug and Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Zoetis Pet Drug and Vaccine Product Portfolio Table 93. Zoetis Recent Development Table 94. Research Programs/Design for This Report Table 95. Authors List of This Report Table 96. Secondary Sources Table 97. Primary Sources List of Figures Figure 1. Pet Drug and Vaccine Product Image Figure 2. Global Pet Drug and Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pet Drug and Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Pet Drug and Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Drugs Image Figure 8. Vaccine Image Figure 9. Global Pet Drug and Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Pet Drug and Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Pet Drug and Vaccine Sales Value Share by Type (2021-2032) Figure 12. Dogs Image Figure 13. Cats Image Figure 14. Other Image Figure 15. Global Pet Drug and Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Pet Drug and Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Pet Drug and Vaccine Sales Value Share by Application (2021-2032) Figure 18. Global Pet Drug and Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Pet Drug and Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Pet Drug and Vaccine Sales Value (2021-2032) & (US$ Million) Figure 21. North America Pet Drug and Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Pet Drug and Vaccine Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Pet Drug and Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Pet Drug and Vaccine Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Pet Drug and Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Pet Drug and Vaccine Sales Value (2021-2032) & (US$ Million) Figure 27. South America Pet Drug and Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Pet Drug and Vaccine Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Pet Drug and Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Pet Drug and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Pet Drug and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Pet Drug and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Pet Drug and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Pet Drug and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Pet Drug and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Pet Drug and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Pet Drug and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Pet Drug and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Pet Drug and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Pet Drug and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Pet Drug and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Pet Drug and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Pet Drug and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Pet Drug and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Pet Drug and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Pet Drug and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Pet Drug and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Pet Drug and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Pet Drug and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Pet Drug and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Pet Drug and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Pet Drug and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Pet Drug and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Pet Drug and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Pet Drug and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Pet Drug and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Pet Drug and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Drugs
  • Vaccine
Applications
  • Dogs
  • Cats
  • Other
Companies covered
  • Boehringer Ingelheim
  • Ceva
  • Dechra Veterinary Products
  • Elanco Animal Health
  • Meiji
  • Merck Animal Health
  • Ouro Fino Saude
  • Parnell
  • Vetoquinol
  • Virbac
  • Zoetis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pet Drug and Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pet Drug and Vaccine Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pet Drug and Vaccine Market Dynamics
  1. 2.1 Pet Drug and Vaccine Industry Trends
  2. 2.2 Pet Drug and Vaccine Industry Drivers
  3. 2.3 Pet Drug and Vaccine Industry Opportunities and Challenges
  4. 2.4 Pet Drug and Vaccine Industry Restraints
3 Pet Drug and Vaccine Market by Company
  1. 3.1 Global Pet Drug and Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global Pet Drug and Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global Pet Drug and Vaccine Company Ranking (2024-2026)
  4. 3.4 Global Pet Drug and Vaccine Company Manufacturing Base and Headquarters
  5. 3.5 Global Pet Drug and Vaccine Company Product Type and Application
  6. 3.6 Global Pet Drug and Vaccine Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pet Drug and Vaccine Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pet Drug and Vaccine Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pet Drug and Vaccine Market by Type
  1. 4.1 Pet Drug and Vaccine Type Introduction
  2. 4.1.1 Drugs
  3. 4.1.2 Vaccine
  4. 4.2 Global Pet Drug and Vaccine Sales Value by Type
  5. 4.2.1 Global Pet Drug and Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pet Drug and Vaccine Sales Value by Type (2021-2032)
  7. 4.2.3 Global Pet Drug and Vaccine Sales Value Share by Type (2021-2032)
5 Pet Drug and Vaccine Market by Application
  1. 5.1 Pet Drug and Vaccine Application Introduction
  2. 5.1.1 Dogs
  3. 5.1.2 Cats
  4. 5.1.3 Other
  5. 5.2 Global Pet Drug and Vaccine Sales Value by Application
  6. 5.2.1 Global Pet Drug and Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pet Drug and Vaccine Sales Value by Application (2021-2032)
  8. 5.2.3 Global Pet Drug and Vaccine Sales Value Share by Application (2021-2032)
6 Pet Drug and Vaccine Regional Value Analysis
  1. 6.1 Global Pet Drug and Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pet Drug and Vaccine Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pet Drug and Vaccine Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pet Drug and Vaccine Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pet Drug and Vaccine Sales Value (2021-2032)
  7. 6.3.2 North America Pet Drug and Vaccine Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pet Drug and Vaccine Sales Value (2021-2032)
  10. 6.4.2 Europe Pet Drug and Vaccine Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pet Drug and Vaccine Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pet Drug and Vaccine Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pet Drug and Vaccine Sales Value (2021-2032)
  16. 6.6.2 South America Pet Drug and Vaccine Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pet Drug and Vaccine Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pet Drug and Vaccine Sales Value Share by Country, 2025 VS 2032
7 Pet Drug and Vaccine Country-level Value Analysis
  1. 7.1 Global Pet Drug and Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pet Drug and Vaccine Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pet Drug and Vaccine Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pet Drug and Vaccine Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pet Drug and Vaccine Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pet Drug and Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pet Drug and Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pet Drug and Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pet Drug and Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pet Drug and Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pet Drug and Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pet Drug and Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pet Drug and Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pet Drug and Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pet Drug and Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pet Drug and Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pet Drug and Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pet Drug and Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pet Drug and Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pet Drug and Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pet Drug and Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pet Drug and Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pet Drug and Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pet Drug and Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pet Drug and Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pet Drug and Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pet Drug and Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pet Drug and Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pet Drug and Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pet Drug and Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pet Drug and Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pet Drug and Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pet Drug and Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pet Drug and Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Boehringer Ingelheim
  2. 8.1.1 Boehringer Ingelheim Company Information
  3. 8.1.2 Boehringer Ingelheim Business Overview
  4. 8.1.3 Boehringer Ingelheim Pet Drug and Vaccine Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Boehringer Ingelheim Pet Drug and Vaccine Product Portfolio
  6. 8.1.5 Boehringer Ingelheim Recent Developments
  7. 8.2 Ceva
  8. 8.2.1 Ceva Company Information
  9. 8.2.2 Ceva Business Overview
  10. 8.2.3 Ceva Pet Drug and Vaccine Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Ceva Pet Drug and Vaccine Product Portfolio
  12. 8.2.5 Ceva Recent Developments
  13. 8.3 Dechra Veterinary Products
  14. 8.3.1 Dechra Veterinary Products Company Information
  15. 8.3.2 Dechra Veterinary Products Business Overview
  16. 8.3.3 Dechra Veterinary Products Pet Drug and Vaccine Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Dechra Veterinary Products Pet Drug and Vaccine Product Portfolio
  18. 8.3.5 Dechra Veterinary Products Recent Developments
  19. 8.4 Elanco Animal Health
  20. 8.4.1 Elanco Animal Health Company Information
  21. 8.4.2 Elanco Animal Health Business Overview
  22. 8.4.3 Elanco Animal Health Pet Drug and Vaccine Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Elanco Animal Health Pet Drug and Vaccine Product Portfolio
  24. 8.4.5 Elanco Animal Health Recent Developments
  25. 8.5 Meiji
  26. 8.5.1 Meiji Company Information
  27. 8.5.2 Meiji Business Overview
  28. 8.5.3 Meiji Pet Drug and Vaccine Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Meiji Pet Drug and Vaccine Product Portfolio
  30. 8.5.5 Meiji Recent Developments
  31. 8.6 Merck Animal Health
  32. 8.6.1 Merck Animal Health Company Information
  33. 8.6.2 Merck Animal Health Business Overview
  34. 8.6.3 Merck Animal Health Pet Drug and Vaccine Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Merck Animal Health Pet Drug and Vaccine Product Portfolio
  36. 8.6.5 Merck Animal Health Recent Developments
  37. 8.7 Ouro Fino Saude
  38. 8.7.1 Ouro Fino Saude Company Information
  39. 8.7.2 Ouro Fino Saude Business Overview
  40. 8.7.3 Ouro Fino Saude Pet Drug and Vaccine Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Ouro Fino Saude Pet Drug and Vaccine Product Portfolio
  42. 8.7.5 Ouro Fino Saude Recent Developments
  43. 8.8 Parnell
  44. 8.8.1 Parnell Company Information
  45. 8.8.2 Parnell Business Overview
  46. 8.8.3 Parnell Pet Drug and Vaccine Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Parnell Pet Drug and Vaccine Product Portfolio
  48. 8.8.5 Parnell Recent Developments
  49. 8.9 Vetoquinol
  50. 8.9.1 Vetoquinol Company Information
  51. 8.9.2 Vetoquinol Business Overview
  52. 8.9.3 Vetoquinol Pet Drug and Vaccine Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Vetoquinol Pet Drug and Vaccine Product Portfolio
  54. 8.9.5 Vetoquinol Recent Developments
  55. 8.10 Virbac
  56. 8.10.1 Virbac Company Information
  57. 8.10.2 Virbac Business Overview
  58. 8.10.3 Virbac Pet Drug and Vaccine Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Virbac Pet Drug and Vaccine Product Portfolio
  60. 8.10.5 Virbac Recent Developments
  61. 8.11 Zoetis
  62. 8.11.1 Zoetis Company Information
  63. 8.11.2 Zoetis Business Overview
  64. 8.11.3 Zoetis Pet Drug and Vaccine Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Zoetis Pet Drug and Vaccine Product Portfolio
  66. 8.11.5 Zoetis Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst